How big is the Global Cancer Therapy Market?

The Global Cancer Therapy Market size is expected to reach USD 220.24 billion in 2024 and grow at a CAGR of 10.64% to reach USD 409.68 billion by 2029. Read More

What is the current Global Cancer Therapy Market size?

In 2024, the Global Cancer Therapy Market size is expected to reach USD 220.24 billion. Read More

Who are the key players in Global Cancer Therapy Market?

Amgen Inc., AstraZeneca PLC, Bayer AG, Johnson and Johnson and Merck & Co. Inc. are the major companies operating in the Global Cancer Therapy Market. Read More

Which is the fastest growing region in Global Cancer Therapy Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Cancer Therapy Market?

In 2024, the North America accounts for the largest market share in Global Cancer Therapy Market. Read More

What years does this Global Cancer Therapy Market cover, and what was the market size in 2023?

In 2023, the Global Cancer Therapy Market size was estimated at USD 196.81 billion. The report covers the Global Cancer Therapy Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Global Cancer Therapy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Cancer Therapy Market Share

Statistics for the 2023 & 2024 Global Cancer Therapy market share, created by Mordor Intelligence™ Industry Reports. Global Cancer Therapy share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Cancer Therapy Industry

The cancer therapy market consists of several major players and is highly competitive. In terms of market share, a few of the major players currently dominate the market. Various strategies are adopted by the market players, such as collaborations and acquisitions for product portfolio development and to expand their capabilities. The players, namely Amgen Inc., AstraZeneca, Bayer AG, Bristol-Myers Squibb Company, Pfizer Inc, Novartis AG, and Johnson & Johnson Services, hold significant shares in the cancer therapy market.